We are live on ! Find out more
TI

tru Independence Portfolio holdings

AUM $202M
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
+16.99%
1 Year Est. Return
+15.81%
3 Year Est. Return
+42.5%
5 Year Est. Return
+46.34%
10 Year Est. Return
–
AUM
$691K
AUM Growth
+$78K
Cap. Flow
+$226M
Cap. Flow %
32,646.26%
Top 10 Hldgs %
41.04%
Holding
960
New
207
Increased
181
Reduced
170
Closed
53

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$61.5M
2
SCHB icon
Schwab US Broad Market ETF
SCHB
+$54.4M
3
IUSG icon
iShares Core S&P US Growth ETF
IUSG
+$28.9M
4
XOP icon
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+$16.7M
5
GLD icon
SPDR Gold Trust
GLD
+$9.38M

Top Sells

Rank Stock Value
1
FBT icon
First Trust NYSE Arca Biotechnology Index Fund
FBT
+$10.7M
2
GIS icon
General Mills
GIS
+$5.39M
3
MSFT icon
Microsoft
MSFT
+$3.32M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$3.24M
5
ENR icon
Energizer
ENR
+$2.86M

Sector Composition

Rank Sector Weight
1 Energy 28.66%
2 Technology 9.15%
3 Healthcare 7.9%
4 Financials 6.09%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGNX icon
751
Cognex
CGNX
$10.3B
$3 ﹤0.01%
46
– –
CMBS icon
752
iShares CMBS ETF
CMBS
$473M
$3 ﹤0.01%
+72
New +$3.88K
DLY
753
DoubleLine Yield Opportunities Fund
DLY
$671M
$3 ﹤0.01%
+150
New +$2.68K
DSL
754
DoubleLine Income Solutions Fund
DSL
$1.21B
$3 ﹤0.01%
+225
New +$3.12K
ETSY icon
755
Etsy
ETSY
$7.65B
$3 ﹤0.01%
+25
New +$1.85K
KPTI icon
756
Karyopharm Therapeutics
KPTI
$168M
$3 ﹤0.01%
+10
New +$2.96K
LX
757
LexinFintech Holdings
LX
$244M
$3 ﹤0.01%
+300
New +$2.67K
NVO
758
Novo Nordisk
NVO
$216B
$3 ﹤0.01%
104
– –
PHG icon
759
Philips
PHG
$25.4B
$3 ﹤0.01%
80
-2
-2% -$70
PLUR icon
760
Pluri
PLUR
$19.2M
$3 ﹤0.01%
+47
New +$3.07K
PNC icon
761
PNC Financial Services
PNC
$100B
$3 ﹤0.01%
24
– –
PSLV icon
762
Sprott Physical Silver Trust
PSLV
$11.9B
$3 ﹤0.01%
+500
New +$3.01K
RPM icon
763
RPM International
RPM
$13.7B
$3 ﹤0.01%
42
– –
SJM icon
764
J.M. Smucker
SJM
$12.6B
$3 ﹤0.01%
33
– –
STAG icon
765
STAG Industrial
STAG
$7.86B
$3 ﹤0.01%
+100
New +$2.63K
SU icon
766
Suncor Energy
SU
$77.7B
$3 ﹤0.01%
200
– –
SUI icon
767
Sun Communities
SUI
$15B
$3 ﹤0.01%
19
– –
USPH icon
768
US Physical Therapy
USPH
$1.14B
$3 ﹤0.01%
40
– –
VFC icon
769
VF Corp
VFC
$6.68B
$3 ﹤0.01%
57
– –
NTCO
770
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$3 ﹤0.01%
240
– –
TYME
771
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$3 ﹤0.01%
2,500
– –
MIC
772
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$3 ﹤0.01%
100
– –
CFRX
773
DELISTED
ContraFect Corporation
CFRX
$3 ﹤0.01%
6
– –
ARAY icon
774
Accuray
ARAY
$28.4M
$2 ﹤0.01%
1,000
– –
ARCC icon
775
Ares Capital
ARCC
$13.5B
$2 ﹤0.01%
+164
New +$2.21K
29 30
31
32 33

Similar funds

4FG
4Thought Financial Group Syosset, New York $202M AUM 11.53% 1-Year Est. Return
BFA
Brendel Financial Advisors Hanover, New Hampshire $202M AUM 37.99% 1-Year Est. Return
PCMK
Paragon Capital Management (Kansas) Overland Park, Kansas $202M AUM 26.44% 1-Year Est. Return
CWM
CarsonAllaria Wealth Management Glen Carbon, Illinois $202M AUM 15.75% 1-Year Est. Return
AFWM
Arta Finance Wealth Management Mountain View, California $202M AUM
HWMO
Heritage Wealth Management (Ohio) Cincinnati, Ohio $202M AUM 23.85% 1-Year Est. Return
PCM
Pointe Capital Management Grosse Pointe Farms, Michigan $202M AUM 17.2% 1-Year Est. Return
BSA
Bull Street Advisors Savannah, Georgia $202M AUM 11.06% 1-Year Est. Return

tru Independence's Q2 2020 Portfolio in Review

As of Q2 2020, tru Independence held 960 positions worth $691K, up 13% from $613K the previous quarter. Its ten largest holdings account for 41% of the portfolio.

tru Independence deployed $226M of net new capital in Q2 2020, opening 207 new positions and adding to 181 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,027,572 shares worth $19.

By sector, the portfolio is most concentrated in Energy at 29% of assets, up from 2.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was First Trust NYSE Arca Biotechnology Index Fund, an estimated $10.7M trimmed.

  • tru Independence's largest Q2 2020 buy was Bristol-Myers Squibb: 1,027,572 shares worth $19.
  • tru Independence added most to SPDR Gold Trust in Q2 2020, an estimated $9.38M increase.
  • tru Independence's biggest Q2 2020 reduction was First Trust NYSE Arca Biotechnology Index Fund, cutting an estimated $10.7M.
  • tru Independence fully exited Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020, selling an estimated $49.3K.
  • tru Independence's ten largest holdings make up 41% of its $691K portfolio in Q2 2020.
  • tru Independence opened 207 new positions and closed 53 in Q2 2020.
  • tru Independence's portfolio value rose 13% quarter-over-quarter to $691K.

Based on tru Independence's 13F filing for Q2 2020, filed 19 Aug 2020.